Home / Clinical Laboratory / Clinical Analyzer Calibrators and Reagents / Reagents / Reagent Kit / Reagent Kit Cobas® Liat® Molecular Diagnostic / Real Time RT-PCR SARS-CoV-2 & Influenza A / B For use on the Cobas® Liat® System 20 tests09211101190
Picture of Reagent Kit Cobas® Liat® Molecular Diagnostic / Real Time RT-PCR SARS-CoV-2 & Influenza A / B For use on the Cobas® Liat® System 20 tests09211101190

Reagent Kit Cobas® Liat® Molecular Diagnostic / Real Time RT-PCR SARS-CoV-2 & Influenza A / B For use on the Cobas® Liat® System 20 tests09211101190

Reagent-Kit-Cobas®-Liat®-Molecular-Diagnostic--Real-Time-RT-PCR-SARS-CoV-2-&-Influenza-A--B-For-use-on-the-Cobas®-Liat®-System-20-tests09211101190

SKU #

#1177911

MPN #

09211101190

Brand

Roche

Stock

In Stock

Quantity

100

Features

ASSAY, SARS COV-2 FLU A/B COBAS LIAT (20TEST/KT)

$860.00 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 1177911
Manufacturer # 09211101190
Brand Cobas® Liat®
Manufacturer Roche
Application Reagent Kit
Container Type Tube
For Use With For use on the Cobas® Liat® System
Number of Tests 20 Tests
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Sample Type Nasal Swab / Nasopharyngeal Swab Sample
Storage Requirements Requires Refrigeration
Test Name SARS-CoV-2 & Influenza A / B
Test Type Molecular Diagnostic / Real Time RT-PCR
Time To Results 20 Minute Results
UNSPSC Code 41116144
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • The cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test is for use on the cobas Liat System under FDA Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Emergency use of this test is limited to authorized laboratories: Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform moderate or high complexity tests
  • The cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas Liat System is also authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
  • The new cobas SARS-CoV-2 & Influenza A/B test analyzes nucleic acids from nasopharyngeal and nasal swab samples and self-collected nasal swabs (collected in a healthcare setting with instruction by a healthcare provider) to enable frontline healthcare workers to quickly identify and differentiate these similarly presenting infections
  • This test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, and influenza B virus and not for any other viruses or pathogens
  • This test is only authorized in the United States for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner
  • Positive results are indicative of active infection but do not rule out bacterial infection or co-infection with other pathogens not detected by the test; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status
  • Negative results do not preclude SARS-CoV-2, influenza A, and/or influenza B infection and should not be used as the sole basis for diagnosis, treatment or other patient management decisions
  • Negative results must be combined with clinical observations, patient history, and/or epidemiological information
  • cobas® SARS-CoV-2 & Influenza A/B is intended for use by health professionals or trained operators who are proficient in using the cobas® Liat System
  • The cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System (cobas® SARS-CoV-2 & Influenza A/B) is an automated multiplex real-time RT-PCR assay intended for the simultaneous rapid in vitro qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B virus RNA
  • Contains sufficient reagents to process 20 specimens or quality control samples
  • Kit includes: 20 tests, 20 transfer pipettes, 1 package insert barcode card, cobas Liat Internal Process Control, Proteinase K, cobas Liat Magnetic Glass Particles, Lysis buffer, wash buffer, Elution buffer, A/B Master Mix 1, A/B Master Mix 2, A/B Master Mix 3